Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study.

Journal:
Diabetes Care
Published:
Affiliations:
28
Authors:
31
Institutions Authors Share
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
4.500000
0.15
Primary Care Research Institute Jordi Gol (IDIAP), UAB, Spain
3.000000
0.10
Yale University, United States of America (USA)
2.333333
0.08
University of California, Los Angeles (UCLA), United States of America (USA)
2.250000
0.07
Johns Hopkins University (JHU), United States of America (USA)
2.000000
0.06
IQVIA, United States of America (USA)
2.000000
0.06
The University of Hong Kong (HKU), China
1.500000
0.05
VA Salt Lake City Health Care System, United States of America (USA)
1.250000
0.04
University of Dundee, United Kingdom (UK)
1.000000
0.03
Peking University (PKU), China
1.000000
0.03
UCLA Health, United States of America (USA)
1.000000
0.03
The University of Utah (Utah), United States of America (USA)
1.000000
0.03
Vanderbilt University Medical Center (VUMC), United States of America (USA)
1.000000
0.03
Johnson & Johnson, United States of America (USA)
1.000000
0.03
Janssen Research & Development, LLC (J&J PRD), United States of America (USA)
1.000000
0.03
VA Tennessee Valley Healthcare System, United States of America (USA)
1.000000
0.03
University of Michigan (U-M), United States of America (USA)
1.000000
0.03
University of Calgary (U of C), Canada
1.000000
0.03
Yale New Haven Hospital (YNHH), United States of America (USA)
0.666667
0.02
Laboratory of Data Discovery for Health (D24H), China
0.500000
0.02
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)
0.500000
0.02
UCL, United Kingdom (UK)
0.500000
0.02